Raymond James & Associates’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.87M Sell
49,580
-1,060
-2% -$184K 0.01% 1294
2024
Q2
$8.26M Buy
50,640
+1,720
+4% +$279K 0.01% 1273
2024
Q1
$8.55M Buy
48,920
+373
+0.8% +$61.2K 0.01% 1253
2023
Q4
$8.18M Sell
48,547
-81
-0.2% -$11.8K 0.01% 1230
2023
Q3
$6.98M Buy
48,628
+1,369
+3% +$223K 0.01% 1262
2023
Q2
$8.7M Sell
47,259
-1,127
-2% -$184K 0.01% 1142
2023
Q1
$7.7M Sell
48,386
-298
-0.6% -$45.8K 0.01% 1191
2022
Q4
$6.61M Sell
48,684
-1,253
-3% -$175K 0.01% 1238
2022
Q3
$5.78M Buy
49,937
+163
+0.3% +$22.2K 0.01% 1274
2022
Q2
$6.04M Buy
49,774
+10,358
+26% +$1.3M 0.01% 1277
2022
Q1
$5.61M Buy
39,416
+7,515
+24% +$1.07M ﹤0.01% 1427
2021
Q4
$5.63M Buy
31,901
+11,308
+55% +$1.89M ﹤0.01% 1474
2021
Q3
$3.18M Buy
20,593
+1,893
+10% +$275K ﹤0.01% 1777
2021
Q2
$2.52M Buy
+18,700
New +$2.52M ﹤0.01% 1939

Other funds holding NOVT

Raymond James & Associates's NOVT Position: Q3 2024 in Review

Raymond James & Associates reduced its Novanta (NOVT) stake by 2.1% in Q3 2024, selling an estimated $184K and leaving 49,580 shares worth $8.87M. The position accounts for 0.01% of the portfolio, ranked #1294.

Raymond James & Associates first reported a position in NOVT in Q2 2021 and has held it in 14 quarters since. 288 funds tracked by Wall St. Rank hold NOVT as of Q3 2024.

  • Raymond James & Associates held 49,580 shares of Novanta worth $8.87M as of Q3 2024.
  • Raymond James & Associates sold 1,060 Novanta shares in Q3 2024, an estimated $184K.
  • Novanta made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1294 holding.
  • Raymond James & Associates first reported a position in Novanta in Q2 2021 and has held it in 14 quarters since.
  • 288 funds tracked by Wall St. Rank held Novanta as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.